Drug-Related Problems in Bariatric Surgery: a Retrospective Study

被引:2
作者
Wang, Yuping [1 ]
Zhu, Jie [2 ,3 ,4 ,5 ]
Shan, Luchen [6 ]
Wang, Cunchuan [2 ,3 ,4 ]
Dong, Zhiyong [2 ,3 ,4 ]
Yang, Wah [2 ,3 ,4 ]
机构
[1] Jinan Univ, Dept Pharm, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Jinan Univ, Dept Metab & Bariatr Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Jinan Univ, Inst Obes & Metab Disorders, Guangzhou, Peoples R China
[4] Guangdong Hong Kong Macao Joint Univ, Lab Metab & Mol Med, Guangzhou, Peoples R China
[5] Second Peoples Hosp Yibin, Dept Gastrointestinal Surg, Yibin, Sichuan, Peoples R China
[6] Jinan Univ, Coll Pharm, Guangzhou, Peoples R China
关键词
Drug-related problems; Bariatric surgery; PCNE; NCC MERP; Perioperative medication; MEDICATION; THERAPY; OBESITY; CARE;
D O I
10.1007/s11695-022-06295-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background With the rapid increase of bariatric surgery worldwide, drug-related problems (DRPs) in this area seem to be rising. This study aimed to investigate the incidence and characteristics of DRPs in patients undergoing bariatric surgery. Methods Medication records for patients who underwent bariatric surgery were analysed retrospectively between January 2019 and December 2020 in our center. We classified and analysed DRPs using the Pharmaceutical Care Network Europe classification (PCNE version 9.0). Rating severity of these DRPs was based on the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) classification. Continuous variables were analysed by Student's t-test, and categorical variables were compared using the chi-square test. One-way ANOVA was used to compare the numbers of DRPs. Results Totally 347 patients were reviewed, and 760 DRPs were identified with an average of 2.19 +/- 1.36 DRPs for each patient. The most common DRPs were problems related to perioperative antibiotics accounting for 29.47%, 25.62% and 14.34% for hepatoprotection and proton-pump inhibitors (PPI), respectively. The leading causes of DRPs were inappropriate medications for antibiotics, hepatoprotection, ancillary drugs and PPI. 89.34% of the DRPs were rated at severity categories B-D (which means potential adverse reactions that may occur), whereas 10.66% were rated as categories E-H. There were relations between DRPs and older (32.22 +/- 9.29 vs. 29.11 +/- 6.53 years), fewer concomitant surgeries (1.89 +/- 1.25 vs. 2.99 +/- 1.31), longer postoperative fasting time (PFT) (1.18 +/- 0.55 vs. 1.06 +/- 0.24 days) and more comorbidities (6.71 +/- 2.63 vs. 5.23 +/- 1.46) (P < 0.05). Conclusions The incidence of DRPs in the perioperative period of bariatric surgery is high. Patients with fewer concomitant surgeries and longer PFT are prone to DRPs. It is necessary for clinical pharmacists to participate in medication monitoring and reviewing to facilitate enhanced recovery after bariatric surgery.
引用
收藏
页码:3961 / 3972
页数:12
相关论文
共 41 条
  • [1] Evaluation of drug therapy problems among renal patients receiving care in some tertiary hospitals in Nigeria
    Adibe, Maxwell O.
    Igboeli, Nneka U.
    Ukwe, Chinwe V.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (03) : 697 - 704
  • [2] Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan
    Al-Azzam, Sayer I.
    Alzoubi, Karem H.
    AbuRuz, Salah
    Alefan, Qais
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 233 - 239
  • [3] [Anonymous], PCNEV9 0
  • [4] Perioperative Antiemetic Therapy for Fast-Track Laparoscopic Bariatric Surgery
    Bamgbade, Olumuyiwa A.
    Oluwole, Oluwafemi
    Khaw, Rong R.
    [J]. OBESITY SURGERY, 2018, 28 (05) : 1296 - 1301
  • [5] Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship
    Blum, Sharon
    Cunha, Cheston B.
    Cunha, Burke A.
    [J]. SURGICAL INFECTIONS, 2019, 20 (06) : 439 - 443
  • [6] Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
    Bratzler, Dale W.
    Dellinger, E. Patchen
    Olsen, Keith M.
    Perl, Trish M.
    Auwaerter, Paul G.
    Bolon, Maureen K.
    Fish, Douglas N.
    Napolitano, Lena M.
    Sawyer, Robert G.
    Slain, Douglas
    Steinberg, James P.
    Weinstein, Robert A.
    [J]. SURGICAL INFECTIONS, 2013, 14 (01) : 73 - 156
  • [7] Che G, 2018, CHIN J CLIN THORAC C, V25, P545
  • [8] Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing
    Chen, Xing
    Brathwaite, Collin E. M.
    Barkan, Alexander
    Hall, Keneth
    Chu, Gloria
    Cherasard, Patricia
    Wang, Shan
    Nicolau, David P.
    Islam, Shahidul
    Cunha, Burke A.
    [J]. OBESITY SURGERY, 2017, 27 (03) : 626 - 629
  • [9] Omeprazole Absorption and Fasting Gastrinemia After Roux-en-Y Gastric Bypass
    Collares-Pelizaro, Renata V. A.
    Santos, Jose S.
    Nonino, Carla B.
    Gaitani, Cristiane M.
    Salgado, Wilson, Jr.
    [J]. OBESITY SURGERY, 2017, 27 (09) : 2303 - 2307
  • [10] The Clinical Pharmacist's Role in Perioperative Surgical Pain Management
    Coulson, Eva E.
    Kral, Lee A.
    [J]. JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2020, 34 (03) : 120 - 126